ABBOTT LABORATORIES Net Cash Provided by (Used in) Financing Activities in USD from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Abbott Laboratories quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2025.
  • Abbott Laboratories Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$2.06B, a 74.7% decline year-over-year.
  • Abbott Laboratories annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$5.4B, a 23.8% increase from 2023.
  • Abbott Laboratories annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$7.09B, a 7.14% increase from 2022.
  • Abbott Laboratories annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$7.64B, a 39% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

ABBOTT LABORATORIES Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$2.06B -$879M -74.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-30
Q1 2024 -$1.18B +$234M +16.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-30
Q1 2023 -$1.41B +$2.41B +63.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 -$3.82B -$2.86B -295% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 -$967M -$232M -31.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q1 2020 -$735M +$407M +35.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 -$1.14B +$5.31B +82.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q1 2018 -$6.46B -$2.06B -46.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q1 2017 -$4.4B -$2.97B -207% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q1 2016 -$1.43B -$882M -160% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q1 2015 -$550M +$602M +52.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q1 2014 -$1.15B +$3.58B +75.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q1 2013 -$4.73B -$4.9B -2965% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q1 2012 $165M +$850M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q1 2011 -$684M -$164M -31.6% Jan 1, 2011 Mar 31, 2011 10-Q 2011-05-06
Q1 2010 -$520M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06

ABBOTT LABORATORIES Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$5.4B +$1.69B +23.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-21
2023 -$7.09B +$545M +7.14% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-21
2022 -$7.64B -$2.14B -39% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-21
2021 -$5.49B -$2.72B -97.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-16
2020 -$2.78B +$1.51B +35.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 -$4.29B +$6.1B +58.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 -$10.4B -$5.11B -96.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 -$5.28B -$16.4B -147% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $11.1B +$13.4B Jan 1, 2016 Dec 31, 2016 10-K 2019-02-22
2015 -$2.24B +$506M +18.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 -$2.74B +$3.95B +59.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 -$6.7B -$6.89B -3534% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
2012 $195M +$6.62B Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 -$6.42B -$5.34B -490% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-21
2010 -$1.09B Jan 1, 2010 Dec 31, 2010 10-K 2011-02-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.